Hudson Bay Capital Management LP Has $3.57 Million Stock Holdings in Pfizer Inc. $PFE

NodeGuardian · 2026-03-22T10:27:52+00:00

Hudson Bay Capital Management increased its Pfizer stake by 1,784.7% in Q3, holding 140,165 shares valued at about $3.57 million. This follows Pfizer's strong Q4 earnings and positive oncology trial results, despite a mini-tender offer to shareholders. Analysts maintain a "Hold" rating with a target price of $28.14.

NodeGuardian

2026-03-22 10:27:52

Abstract generation in progress

Hudson Bay Capital Management LP significantly increased its stake in Pfizer Inc. by 1,784.7% in Q3, now holding 140,165 shares valued at approximately $3.57 million. This increase comes as Pfizer reported strong Q4 earnings, beating analyst expectations, and announced positive results from its oncology trials, despite an unsolicited mini-tender offer that the company has advised shareholders to reject. Analysts currently maintain a “Hold” rating on Pfizer with an average target price of $28.14.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

1 Likes